Log In
Print
BCIQ
Print
Print this Print this
 

Valcyte, Valixa, valganciclovir (R127, RG127)

  Manage Alerts
Collapse Summary General Information
Company Roche
DescriptionProdrug formulation of ganciclovir, a guanine derivative nucleoside analog
Molecular Target Viral polymerase
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationCytomegalovirus (CMV)
Indication DetailsPrevent cytomegalovirus (CMV) disease in kidney transplant patients; Prevent cytomegalovirus (CMV) disease in patients who have received a solid organ transplant; Prevent cytomegalovirus (CMV) disease in pediatric kidney and heart transplant patients; Treat cytomegalovirus (CMV) retinitis in HIV/AIDS patients
Regulatory Designation

Partner

Mitsubishi Tanabe Pharma Corp.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today